Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

John P. Palmer; Arief A. Suriawinata; Shaofeng Yan; Darcy A. Kerr; Muhammad Z. Afzal; Keisuke Shirai

doi:10.12659/AJCR.938537

18 November 2023 : Case report USA

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

Unusual or unexpected effect of treatment

John P. Palmer^1ADEF*, Arief A. Suriawinata^2BDE, Shaofeng Yan^2BDE, Darcy A. Kerr^2BDE, Muhammad Z. Afzal^1ABCE, Keisuke Shirai^1ADEF

DOI: 10.12659/AJCR.938537

Am J Case Rep 2023; 24:e938537

Authors information Article notes Copyright and License information

Background Case Reports Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. Case 1: (A) PET/CT obtained on November 3, 2020, showing a 31×24-mm FDG-avid mesenteric nodal mass in the left mid abdomen consistent with active nodal metastasis. (B) PET/CT obtained on December 20, 2022, with no evidence of active metastatic disease.

Back to the Article

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

Your Privacy